Antiva Biosciences, Inc.

Venture capital fundraising by biopharmaceutical companies has been a mixed bag so far in 2023, with a slow start to the year but a relative surge in big financings in March and April. There were only

The biotechnology company creator and funder Flagship Pioneering and the Cystic Fibrosis Foundation announced a strategic partnership on 3 November under which the CF Foundation has committed up to

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma

Venture capital investment in biopharmaceutical companies totaled $9.7bn in the first half of this year, so if the pace of $4.8bn per quarter keeps up, 2018 will beat the $12.4bn invested in private d